Controlled drug delivery from a novel injectable in situ formed biodegradable PLGA microsphere system

... .. ........ .. .. ..... .. ... ..... .... ... .. ...... ..... ...... .... .. . ACKNOWLEDGEMENT .... ......... ........ .... ...... .... ... .. ... ......... ......... ....... .... .. ... .. .. ... . iv PREFACE ... ...... ... .. ... ......... .. .. ..... ....... ......... .. vi LIST OF TABLES ... .... .. .... ..... .. ...... .. ......... .. .... ... ... .. ... ......... ... ix LIST OF FIGURES ..... ... ..... .... .... ... ....... ..... ......... ..... .. .. .. .. x LIST OF PUBLICATIONS ..... ..... .. ..... .. ..... ....... ... .. ... ... ....... ... ..... ... .. ...... xiv

• Publication year

  1998

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.23860/diss-jain-rajeev-1998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivo. A histological and immunohistochemical study.

  2009cited by this paper
• Double-walled microparticles for single shot vaccine

  1997cited by this paper
• Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervation

  1997cited by this paper
• In vitro and in vivo respirable fractions of isopropanol treated PLGA microspheres using a dry powder inhaler

  1997cited by this paper
• In vitro and in vivo release of estradiol from an intra-muscular microsphere formulation

  1997cited by this paper
• Influence of the Degrees of Hydrolyzation and Polymerization of Poly(vinylalchol)on the Preparation and Properties of Poly(DL-lactide-co-glycolide)nanoparticle.

  1997cited by this paper
• Effect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalers1

  1997cited by this paper
• Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.

  1997cited by this paper
• Preparation and subsequent degradation of poly(l-lactic acid) microspheres suitable for aerosolisation: a physico-chemical study

  1997cited by this paper
• Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres

  1997cited by this paper
• Plasticizer uptake by aqueous colloidal polymer dispersions used for the coating of solid dosage forms

  1997cited by this paper
• Biodegradable cisplatin microspheres for direct brain injection: preparation and characterization.

  1997cited by this paper
• Sustained release of a water-soluble GP IIb/IIIa antagonist from copoly(dl-lactic/glycolic)acid microspheres

  1997cited by this paper
• Development of a single-shot subunit vaccine for HIV-1.

  1997cited by this paper
• Preparation of biodegradable microcapsules of zidovudine using solvent evaporation: Effect of the modification of aqueous phase

  1996cited by this paper
• Investigation of the mechanisms governing the release of levamisole from poly-lactide-co-glycolide delivery systems

  1996cited by this paper
• Mechanisms of isoniazid release from poly(d,l-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods.

  1996cited by this paper
• In vitro release test system of (d,l-lactic-glycolic) acid copolymer microcapsules for sustained release of LHRH agonist (leuprorelin)

  1996cited by this paper
• Effect of molecular weight and storage times on tolmetin release from poly-d,l-lactide microspheres to lipid model membrane. A calorimetric study

  1996cited by this paper
• Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles

  1996cited by this paper
• Antibody production by administration of biodegradable granules incorporating antigen through different injection routes

  1996cited by this paper
• Extended release of recombinant adenovirus from PLGA microspheres

  1996cited by this paper
• Modulation of release rates from double-layer poly (lactic-co-glycolic acid) films for periadventital implants in restenosis

  1996cited by this paper
• Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate.

  1996cited by this paper
• Pulsed controlled-released system for potential use in vaccine delivery.

  1996cited by this paper
• Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks

  1996cited by this paper
• Biodegradable nanoparticles — From sustained release formulations to improved site specific drug delivery

  1996cited by this paper
• In vivo suppressive effects of copoly(glycolic/L-lactic acid) microspheres containing CDDP on murine tumor cells

  1996cited by this paper
• Hydrolytic degradation of poly(DL-lactic acid) in the presence of caffeine base

  1996cited by this paper
• Reversion of multidrug resistance using nanoparticles in vitro: Influence of the nature of the polymer

  1996cited by this paper
• Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles

  1996cited by this paper
• The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2.

  1996cited by this paper
• Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.

  1996cited by this paper
• Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.

  1996cited by this paper
• Controlled delivery of antigens and adjuvants in vaccine development.

  1996cited by this paper
• The effect of the stability of the multiple emulsion on the preparation of polylactide microspheres containing a hydrophilic drug

  1996cited by this paper
• In vitro and in vivo evaluation of polylactide and polylactide-co-glycolide microspheres of morphine for site-specific delivery

  1996cited by this paper
• Factors influencing release of salbutamol sulphate from poly(lactide-co-glycolide) microspheres prepared by water-in-oil-in-water emulsion technique

  1996cited by this paper
• Preparation and evaluation of insulin-loaded poly(dl-lactide) microspheres using an experimental design

  1996cited by this paper
• Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique

  1996cited by this paper
• Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors

  1996cited by this paper
• Low-density poly(dl-lactide-co-glycolide) foams for prolonged release of isoniazid

  1996cited by this paper
• Evaluation of PLGA microsphere size effect on myotoxicity using the isolated rodent skeletal muscle model.

  1996cited by this paper
• Effect of preparative parameters on the characteristics of poly d,l-lactide-co-glycolide)microspheres made by the double emulsion method

  1996cited by this paper
• Degradation of DL-PLA-methadone microspheres during in vitro release

  1996cited by this paper
• Analysis of Erosion Induced Surface Expansion of Poly(Lactic-co-Glycolide) Microparticles

  1996cited by this paper
• Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization

  1995cited by this paper
• Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers.

  1995cited by this paper
• Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems.

  1995cited by this paper
• Initial study of guided tissue regeneration in Class II furcation defects after use of a biodegradable barrier.

  1995cited by this paper
• Effects of H+ liberated from hydrolytic cleavage of polyester microcapsules on their permeability and degradability.

  1995cited by this paper
• Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant

  1995cited by this paper
• Biodegradable submicron carriers for peptide drugs : Preparation of DL-lactide/glycolide copolymer(PLGA)nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system.

  1995cited by this paper
• Physico-chemical characterization of a polymeric injectable implant delivery system

  1995cited by this paper
• Microencapsulation by coacervation of poly(lactide-co-glycolide). IV. Effect of the processing parameters on coacervation and encapsulation

  1995cited by this paper
• Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery

  1995cited by this paper
• Preparation of porous and nonporous biodegradable polymeric hollow microspheres

  1995cited by this paper
• A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles

  1995cited by this paper
• Aqueous colloidal polymer dispersions of biodegradable DL-lactide/glycolide copolymer as basis for latex films: A new approach for the development of biodegradable depot systems

  1995cited by this paper
• Effects of preparation conditions of cisplatin-loaded microspheres on the in vitro release

  1995cited by this paper
• Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release.

  1995cited by this paper
• Biodegradable microparticles as a delivery system for the allergens of Dermatophagoides pteronyssinus (house dust mite): I. Preparation and characterization of microparticles

  1995cited by this paper
• Dexamethasone-nanoparticles for intra-arterial localization in restenosis in rats

  1995cited by this paper
• Controlled release of protein from emulsion freeze-dried PLGA scaffolds

  1995cited by this paper
• Nanoparticles for site specific delivery of U-86983 in restenosis in pig coronary arteries

  1995cited by this paper
• Encyclopedic Handbook of Biomaterials and Bioengineering

  1995cited by this paper
• In vivo biocompatibility study of ABA copolymers

  1995cited by this paper
• The influence of biodegradable microcapsule formulations on the controlled release of a protein

  1994cited by this paper
• Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.

  1994cited by this paper
• Controlled release of thyrotropin releasing hormone from microspheres: evaluation of release profiles and pharmacokinetics after subcutaneous administration.

  1994cited by this paper
• In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres.

  1994cited by this paper
• Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.

  1994cited by this paper
• Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects.

  1994cited by this paper
• Novel Approaches to Controlled-Release Antigen Delivery

  1994cited by this paper
• Microencapsulation by coacervation of poly(lactide‐co‐glycolide). III. Characterization of the final microspheres

  1994cited by this paper
• In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.

  1994cited by this paper
• Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation

  1994cited by this paper
• Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

  1994cited by this paper
• Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymers.

  1994cited by this paper
• Piroxicam release from spray-dried biodegradable microspheres.

  1994cited by this paper
• Resorbable polymeric microspheres for drug delivery--production and simultaneous surface modification using PEO-PPO surfactants.

  1994cited by this paper
• Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique

  1994cited by this paper
• Biodegradable long-circulating polymeric nanospheres.

  1994cited by this paper
• Bioavailability and chemotherapeutic activity of clofazimine against Mycobacterium avium complex infections in beige mice following a single implant of a biodegradable polymer.

  1994cited by this paper
• Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres

  1993cited by this paper
• Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.

  1993cited by this paper
• New advances in vaccine delivery systems.

  1993cited by this paper
• Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.

  1993cited by this paper
• A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) acid (PLGA) copolymers

  1993cited by this paper
• Evaluation of 90:10 poly(D,L-lactide-co-glycolide) microspheres containing norethisterone: drug release and biodegradation.

  1993cited by this paper
• Biodegradable microparticles for oral immunization.

  1993cited by this paper
• Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers.

  1993cited by this paper
• Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres.

  1993cited by this paper
• Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli.

  1993cited by this paper
• Biodegradable delivery system for single step immunization with tetanus toxoid

  1993cited by this paper
• Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior.

  1993cited by this paper
• Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide).

  1993cited by this paper
• Formulation study of leuprorelin acetate to improve clinical performance.

  1992cited by this paper
• Parameters affecting the immunogenicity of microencapsulated tetanus toxoid.

  1992cited by this paper
• Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.

  1992cited by this paper

• No citing papers are available for this paper.